Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL487371 | 1.00 | USP2 (0.31) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL487300 | 0.97 | — | — | |
| SCHEMBL28508223 | 0.90 | — | — | |
| SCHEMBL28209111 | 0.89 | CETP (0.32) | CYP1A2 | |
| SCHEMBL8015433 | 0.88 | — | — | |
| SCHEMBL9787741 | 0.88 | — | — | |
| SCHEMBL15830654 | 0.87 | USP2 (0.34) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL20310250 | 0.87 | — | — | |
| SCHEMBL11118086 | 0.87 | CETP (0.33) | CYP1A2TSHR | |
| SCHEMBL28074451 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062293-A1 | MASS PRODUCTION METHOD FOR HIGH-PURITY LITHIUM SULFIDE USING INLINE-MIXER | LAKE TECHNOLOGY., LTD (KR) | 2026-03-05 | — | — | US | claimed |
| US-20260062292-A1 | MASS PRODUCTION METHOD FOR HIGH-PURITY LITHIUM SULFIDE USING HIGH SPEED STIRRING | LAKE TECHNOLOGY., LTD (KR) | 2026-03-05 | — | — | US | claimed |
| US-20260062291-A1 | MASS PRODUCTION METHOD FOR HIGH-PURITY LITHIUM SULFIDE USING INERT GAS BUBBLING | LAKE TECHNOLOGY., LTD (KR) | 2026-03-05 | — | — | US | claimed |
| CN-119236429-A | Production device, production method and application for preparing alpha-olefin | 中化学科学技术研究有限公司 | 2025-01-03 | — | — | CN | claimed |
| US-7393956-B2 | Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-01 | — | — | US | claimed |
| US-7276567-B2 | Heterocyclic substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-10-02 | — | — | US | claimed |
| US-20260062292-A1 | MASS PRODUCTION METHOD FOR HIGH-PURITY LITHIUM SULFIDE USING HIGH SPEED STIRRING | LAKE TECHNOLOGY., LTD (KR) | 2026-03-05 | — | — | US | disclosed |
| US-20260062291-A1 | MASS PRODUCTION METHOD FOR HIGH-PURITY LITHIUM SULFIDE USING INERT GAS BUBBLING | LAKE TECHNOLOGY., LTD (KR) | 2026-03-05 | — | — | US | disclosed |
| US-20260061385-A1 | MASS PRODUCTION APPARATUS FOR HIGH-PURITY LITHIUM SULFIDE | LAKE TECHNOLOGY., LTD (KR) | 2026-03-05 | — | — | US | disclosed |
| US-20260062293-A1 | MASS PRODUCTION METHOD FOR HIGH-PURITY LITHIUM SULFIDE USING INLINE-MIXER | LAKE TECHNOLOGY., LTD (KR) | 2026-03-05 | — | — | US | disclosed |
| US-12454497-B2 | Fuels and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2025-10-28 | — | — | US | disclosed |
| CN-119236429-A | Production device, production method and application for preparing alpha-olefin | 中化学科学技术研究有限公司 | 2025-01-03 | — | — | CN | disclosed |
| US-20240368054-A1 | FUELS AND METHODS OF MAKING THE SAME | Alliance for Energy Innovation, LLC | 2024-11-07 | — | — | US | disclosed |
| EP-0609335-A1 | METHODS FOR THE TREATMENT OF HYPERLIPIDEMIA USING AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-08-10 | — | — | EP | disclosed |
| WO-1994016677-A1 | DETERGENT MIXTURES WITH IMPROVED BRIGHTENING PROPERTIES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1994-08-04 | — | — | WO | disclosed |
| EP-0587800-A4 | IMMUNOMODULATORY AZASPIRANES | SMITHKLINE BEECHAM CORP (US) | 1994-06-29 | — | — | EP | disclosed |
| EP-0587800-A1 | IMMUNOMODULATORY AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-03-23 | — | — | EP | disclosed |
| WO-1989002889-A1 | IMMUNOMODULATORY AZASPIRANES | SMITHKLINE BECKMAN CORPORATION (US) | 1989-04-06 | — | — | WO | disclosed |
| US-4254214-A | BLACK, REDUCTION OF COPPER SALT OR COMPLEX TO COPPER | FUJI PHOTO FILM CO., LTD. (JP) | 1981-03-03 | — | — | US | disclosed |
| US-4159943-A | Froth flotation of ores using hydrocarbyl bicarbonates | PETROVICH VOJISLAV | 1979-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12454497-B2 | Fuels and methods of making the same | ACADM, SCD, FASN | USP2 2209/4885ALDH1A1 479/4885LMNA 2794/4885 |
| US-20260062291-A1 | MASS PRODUCTION METHOD FOR HIGH-PURITY LITHIUM SULFIDE USING INERT GAS BUBBLING | MGMT, TMCO1, TST | USP2 611/4885ALDH1A1 3840/4885LMNA 1168/4885 |
| US-20240368054-A1 | FUELS AND METHODS OF MAKING THE SAME | ACADM, SCD, FASN | USP2 2209/4885ALDH1A1 479/4885LMNA 2794/4885 |
| US-20260062293-A1 | MASS PRODUCTION METHOD FOR HIGH-PURITY LITHIUM SULFIDE USING INLINE-MIXER | DACH1, RPL22, LAGE3 | USP2 622/4885ALDH1A1 4110/4885LMNA 239/4885 |
| US-20260062292-A1 | MASS PRODUCTION METHOD FOR HIGH-PURITY LITHIUM SULFIDE USING HIGH SPEED STIRRING | DACH1, TMCO1, RPL22 | USP2 924/4885ALDH1A1 3987/4885LMNA 731/4885 |
| US-20260061385-A1 | MASS PRODUCTION APPARATUS FOR HIGH-PURITY LITHIUM SULFIDE | LRRK2, KCNH1, SRMS | USP2 1509/4885ALDH1A1 3616/4885LMNA 2522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.